Insider Selling: Analogic Co. (ALOG) Insider Sells 180 Shares of Stock
Analogic Co. (NASDAQ:ALOG) insider James Patrick Ryan sold 180 shares of the business’s stock in a transaction on Monday, April 17th. The stock was sold at an average price of $71.25, for a total transaction of $12,825.00. Following the transaction, the insider now directly owns 1,490 shares in the company, valued at $106,162.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
James Patrick Ryan also recently made the following trade(s):
- On Wednesday, March 15th, James Patrick Ryan sold 180 shares of Analogic stock. The stock was sold at an average price of $74.65, for a total transaction of $13,437.00.
- On Wednesday, February 15th, James Patrick Ryan sold 180 shares of Analogic stock. The stock was sold at an average price of $81.10, for a total transaction of $14,598.00.
Analogic Co. (NASDAQ:ALOG) traded down 0.78% during mid-day trading on Tuesday, reaching $70.00. 52,076 shares of the company traded hands. Analogic Co. has a 52-week low of $69.65 and a 52-week high of $95.85. The company has a market capitalization of $874.23 million, a P/E ratio of 37.57 and a beta of 0.85. The stock has a 50 day moving average price of $75.45 and a 200-day moving average price of $81.61.
Analogic (NASDAQ:ALOG) last released its quarterly earnings data on Monday, March 6th. The medical research company reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.21. Analogic had a return on equity of 7.14% and a net margin of 2.58%. The firm had revenue of $131.50 million for the quarter, compared to the consensus estimate of $130.45 million. During the same quarter in the prior year, the company posted $1.18 earnings per share. The firm’s revenue was up 2.8% on a year-over-year basis. Analysts expect that Analogic Co. will post $2.71 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 31st. Investors of record on Friday, March 17th were issued a $0.10 dividend. The ex-dividend date of this dividend was Wednesday, March 15th. This represents a $0.40 dividend on an annualized basis and a yield of 0.57%. Analogic’s dividend payout ratio is currently 37.74%.
TRADEMARK VIOLATION WARNING: “Insider Selling: Analogic Co. (ALOG) Insider Sells 180 Shares of Stock” was published by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at http://www.dailypolitical.com/2017/04/18/insider-selling-analogic-co-alog-insider-sells-180-shares-of-stock.html.
Institutional investors have recently added to or reduced their stakes in the company. Louisiana State Employees Retirement System increased its position in shares of Analogic by 2.0% in the first quarter. Louisiana State Employees Retirement System now owns 5,100 shares of the medical research company’s stock valued at $387,000 after buying an additional 100 shares during the period. Capstone Asset Management Co. increased its position in shares of Analogic by 17.9% in the first quarter. Capstone Asset Management Co. now owns 3,826 shares of the medical research company’s stock valued at $290,000 after buying an additional 580 shares during the period. First National Bank of Omaha increased its position in shares of Analogic by 18.6% in the first quarter. First National Bank of Omaha now owns 13,881 shares of the medical research company’s stock valued at $1,054,000 after buying an additional 2,174 shares during the period. Norges Bank bought a new position in shares of Analogic during the fourth quarter valued at approximately $8,170,000. Finally, Summit Global Investments bought a new position in shares of Analogic during the fourth quarter valued at approximately $390,000.
A number of research firms have recently commented on ALOG. Sidoti began coverage on shares of Analogic in a research report on Monday, January 23rd. They set a “neutral” rating and a $88.00 target price on the stock. TheStreet cut shares of Analogic from a “b-” rating to a “c+” rating in a research report on Thursday, January 12th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $91.00.
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Co. and related companies with MarketBeat.com's FREE daily email newsletter.